BIOMAT Database Logo BIOMAT Database Logo

Involvement of tumor necrosis factor-alpha in the pathogenesis of activated macrophage-mediated hepatitis in mice. 1990

J Nagakawa, and I Hishinuma, and K Hirota, and K Miyamoto, and T Yamanaka, and K Tsukidate, and K Katayama, and I Yamatsu
Tsukuba Research Laboratories, Eisai Company Limited, Ibaraki, Japan.

The possible involvement of tumor necrosis factor-alpha in the pathogenesis of an experimentally induced hepatitis was investigated. Balb/c mice were primed with Propionibacterium acnes to induce the infiltration of mononuclear cells into the liver. Immunohistochemical study showed that most of the accumulated mononuclear cells at 7 days were Mac-2 positive, suggesting that they were activated macrophages. An injection of lipopolysaccharide resulted in massive hepatic necrosis and high mortality in the mice within 24 hours. Plasma tumor necrosis factor-alpha activity initially rose sharply and then declined over 3 hours. The increase in plasma aminotransferase activity correlated well with the elevation of plasma tumor necrosis factor-alpha activity. Pretreatment with dexamethasone or 16,16-dimethyl-prostaglandin E2 attenuated not only the elevation of plasma tumor necrosis factor-alpha activity but also the increase in plasma aminotransferase activity and improved the survival rate. Passive immunization against tumor necrosis factor-alpha showed protective effects. These findings suggest that tumor necrosis factor-alpha released from activated macrophages may play a crucial role in the pathogenesis of this murine hepatitis.

UI MeSH Term Description Entries
D007116 Immunization, Passive Transfer of immunity from immunized to non-immune host by administration of serum antibodies, or transplantation of lymphocytes (ADOPTIVE TRANSFER). Convalescent Plasma Therapy,Immunoglobulin Therapy,Immunotherapy, Passive,Normal Serum Globulin Therapy,Passive Antibody Transfer,Passive Transfer of Immunity,Serotherapy,Passive Immunotherapy,Therapy, Immunoglobulin,Antibody Transfer, Passive,Passive Immunization,Therapy, Convalescent Plasma,Transfer, Passive Antibody
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D008262 Macrophage Activation The process of altering the morphology and functional activity of macrophages so that they become avidly phagocytic. It is initiated by lymphokines, such as the macrophage activation factor (MAF) and the macrophage migration-inhibitory factor (MMIF), immune complexes, C3b, and various peptides, polysaccharides, and immunologic adjuvants. Activation, Macrophage,Activations, Macrophage,Macrophage Activations
D008297 Male Males
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D003907 Dexamethasone An anti-inflammatory 9-fluoro-glucocorticoid. Hexadecadrol,Decaject,Decaject-L.A.,Decameth,Decaspray,Dexasone,Dexpak,Hexadrol,Maxidex,Methylfluorprednisolone,Millicorten,Oradexon,Decaject L.A.
D006520 Hepatitis, Animal INFLAMMATION of the LIVER in non-human animals. Animal Hepatitides,Animal Hepatitis,Hepatitides, Animal
D000410 Alanine Transaminase An enzyme that catalyzes the conversion of L-alanine and 2-oxoglutarate to pyruvate and L-glutamate. (From Enzyme Nomenclature, 1992) EC 2.6.1.2. Alanine Aminotransferase,Glutamic-Pyruvic Transaminase,SGPT,Alanine-2-Oxoglutarate Aminotransferase,Glutamic-Alanine Transaminase,Alanine 2 Oxoglutarate Aminotransferase,Aminotransferase, Alanine,Aminotransferase, Alanine-2-Oxoglutarate,Glutamic Alanine Transaminase,Glutamic Pyruvic Transaminase,Transaminase, Alanine,Transaminase, Glutamic-Alanine,Transaminase, Glutamic-Pyruvic
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014409 Tumor Necrosis Factor-alpha Serum glycoprotein produced by activated MACROPHAGES and other mammalian MONONUCLEAR LEUKOCYTES. It has necrotizing activity against tumor cell lines and increases ability to reject tumor transplants. Also known as TNF-alpha, it is only 30% homologous to TNF-beta (LYMPHOTOXIN), but they share TNF RECEPTORS. Cachectin,TNF-alpha,Tumor Necrosis Factor Ligand Superfamily Member 2,Cachectin-Tumor Necrosis Factor,TNF Superfamily, Member 2,TNFalpha,Tumor Necrosis Factor,Cachectin Tumor Necrosis Factor,Tumor Necrosis Factor alpha

Related Publications

J Nagakawa, and I Hishinuma, and K Hirota, and K Miyamoto, and T Yamanaka, and K Tsukidate, and K Katayama, and I Yamatsu
Pathogenesis of herpes simplex hepatitis in macrophage-depleted mice: possible involvement of tumor necrosis factor-alpha and inducible nitric oxide synthase in massive apoptosis.
December 2005, Anatomical science international,
J Nagakawa, and I Hishinuma, and K Hirota, and K Miyamoto, and T Yamanaka, and K Tsukidate, and K Katayama, and I Yamatsu
Involvement of tumor necrosis factor alpha in experimentally induced hepatitis.
April 1991, Gastroenterology,
J Nagakawa, and I Hishinuma, and K Hirota, and K Miyamoto, and T Yamanaka, and K Tsukidate, and K Katayama, and I Yamatsu
Involvement of endotoxins or tumor necrosis factor-alpha in macrophage-mediated oxidation of low density lipoprotein.
July 1998, FEBS letters,
J Nagakawa, and I Hishinuma, and K Hirota, and K Miyamoto, and T Yamanaka, and K Tsukidate, and K Katayama, and I Yamatsu
Involvement of tumor necrosis factor-alpha in the pathogenesis of autoimmune orchitis in rats.
June 2003, Biology of reproduction,
J Nagakawa, and I Hishinuma, and K Hirota, and K Miyamoto, and T Yamanaka, and K Tsukidate, and K Katayama, and I Yamatsu
Involvement of tumor necrosis factor-alpha in the pathogenesis of experimental and human glomerulonephritis.
January 1995, Advances in nephrology from the Necker Hospital,
J Nagakawa, and I Hishinuma, and K Hirota, and K Miyamoto, and T Yamanaka, and K Tsukidate, and K Katayama, and I Yamatsu
Role of tumor necrosis factor alpha in pathogenesis of pneumococcal pneumonia in mice.
January 1997, Infection and immunity,
J Nagakawa, and I Hishinuma, and K Hirota, and K Miyamoto, and T Yamanaka, and K Tsukidate, and K Katayama, and I Yamatsu
Tumor necrosis factor alpha-mediated asthma?.
January 2013, International archives of allergy and immunology,
J Nagakawa, and I Hishinuma, and K Hirota, and K Miyamoto, and T Yamanaka, and K Tsukidate, and K Katayama, and I Yamatsu
Involvement of nuclear factor-kappa B in platelet-activating factor-mediated tumor necrosis factor-alpha expression.
November 1997, European journal of immunology,
J Nagakawa, and I Hishinuma, and K Hirota, and K Miyamoto, and T Yamanaka, and K Tsukidate, and K Katayama, and I Yamatsu
Silica-induced apoptosis in murine macrophage: involvement of tumor necrosis factor-alpha and nuclear factor-kappaB activation.
July 2002, American journal of respiratory cell and molecular biology,
J Nagakawa, and I Hishinuma, and K Hirota, and K Miyamoto, and T Yamanaka, and K Tsukidate, and K Katayama, and I Yamatsu
Augmentation of pulmonary foreign body granulomatous inflammation in mice by lipopolysaccharide: involvement of macrophage activation and tumor necrosis factor-alpha.
January 1992, International archives of allergy and immunology,
Copied contents to your clipboard!